Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Cardiology
Biotechnology
FDA
Health
Mental Health
Medical Devices
Research
Hospitals
Surgery
Science
Clinical Trials
LivaNova PLC

More Like This

Business Wire logo

LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

Business Wire logo

LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results

Business Wire logo

LivaNova to Announce Second-Quarter 2024 Results

Business Wire logo

LivaNova to Announce Third-Quarter 2024 Results

Business Wire logo

LivaNova to Announce First-Quarter 2024 Results

Business Wire logo

LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results

Business Wire logo

LivaNova Reports First-Quarter 2024 Results

Business Wire logo

LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us